ProCE Banner Activity

Novel Anti-HER2–Targeted Tyrosine Kinase Inhibitors

Slideset Download
Download this slideset on newer TKIs for relapsed or refractory HER2-positive metastatic breast cancer.

Released: May 29, 2020

Expiration: May 28, 2021

Share

Faculty

Cristina Saura

Cristina Saura, MD, PhD

Medical Oncologist
Vall d’Hebron University Hospital
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Cristina Saura, MD, PhD

Medical Oncologist
Vall d’Hebron University Hospital
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain